middle.news
How Proteomics International is Revolutionizing Disease Detection with New Blood Tests
9:58am on Monday 27th of October, 2025 AEDT
•
Healthcare
Read Story
How Proteomics International is Revolutionizing Disease Detection with New Blood Tests
9:58am on Monday 27th of October, 2025 AEDT
Key Points
ISO 15189 certification granted for Australian diagnostic laboratory
National launches of PromarkerD (diabetic kidney disease) and PromarkerEso (esophageal cancer)
CPT PLA billing code awarded for PromarkerD in the US, enabling reimbursement
Founder and Managing Director Dr Richard Lipscombe to retire in February 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Proteomics International Laboratories (ASX:PIQ)
OPEN ARTICLE